Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Madlener

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|September 8, 2001
ThrombophiliaB Pötzsch, K Madlener
Hamostaseologie|January 31, 2006
[The management of patients with heparin-induced thrombocytopenia]B Pötzsch, K Madlener
Herz|April 28, 2012
[New anticoagulant drugs for atrial fibrillation. Feasibility and necessity of monitoring]K Madlener, C Hamm
The New England Journal of Medicine|August 19, 2000
Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopeniaB Pötzsch, W P Klövekorn, K Madlener
Thrombosis and Haemostasis|December 1, 1996
The use of heparinase improves the specificity of crossreactivity testing in heparin-induced thrombocytopeniaB Pötzsch, M Keller, K Madlener, et al.
Thrombosis and Haemostasis|August 6, 2000
Application of the TaqMan-PCR for genotyping of the prothrombin G20210A mutation and of the thermolabile methylenetetrahydrofolate reductase mutationD Happich, K Madlener, R Schwaab, et al.
Thrombosis Research|June 1, 1997
Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assayB Pötzsch, S Hund, K Madlener, et al.
Thrombosis and Haemostasis|May 1, 1997
Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass--assessment of the whole blood ecarin clotting timeB Pötzsch, K Madlener, C Seelig, et al.
Journal of Cardiothoracic and Vascular Anesthesia|June 1, 1997
Recombinant hirudin is a heparin alternative in cardiac surgeryF C Riess, N Bleese, J Kormann, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1996
A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgeryF C Riess, B Pötzsch, R Bader, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|September 8, 2001
ThrombophiliaB Pötzsch, K Madlener
Hamostaseologie|January 31, 2006
[The management of patients with heparin-induced thrombocytopenia]B Pötzsch, K Madlener
Herz|April 28, 2012
[New anticoagulant drugs for atrial fibrillation. Feasibility and necessity of monitoring]K Madlener, C Hamm
The New England Journal of Medicine|August 19, 2000
Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopeniaB Pötzsch, W P Klövekorn, K Madlener
Thrombosis and Haemostasis|December 1, 1996
The use of heparinase improves the specificity of crossreactivity testing in heparin-induced thrombocytopeniaB Pötzsch, M Keller, K Madlener, et al.
Thrombosis and Haemostasis|August 6, 2000
Application of the TaqMan-PCR for genotyping of the prothrombin G20210A mutation and of the thermolabile methylenetetrahydrofolate reductase mutationD Happich, K Madlener, R Schwaab, et al.
Thrombosis Research|June 1, 1997
Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assayB Pötzsch, S Hund, K Madlener, et al.
Thrombosis and Haemostasis|May 1, 1997
Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass--assessment of the whole blood ecarin clotting timeB Pötzsch, K Madlener, C Seelig, et al.
Journal of Cardiothoracic and Vascular Anesthesia|June 1, 1997
Recombinant hirudin is a heparin alternative in cardiac surgeryF C Riess, N Bleese, J Kormann, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1996
A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgeryF C Riess, B Pötzsch, R Bader, et al.
Pageof 2